Clinical Trial

Coordinated Reset Deep Brain Stimulation for Parkinson's Disease

Study acronym: CR DBS PD
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Deep brain stimulation (DBS) is a surgical implant procedure for the treatment of Parkinson's Disease (PD) utilizing medical devices approved by the FDA. A novel approach to current DBS approaches is called "Coordinated Reset" DBS (CR-DBS) which uses different patterns of stimulation at lower currents and can address the limitations of traditional DBS (T-DBS) that uses continuous high amplitude and high frequency stimulation. This study will evaluate the safety and short-term efficacy of CR-DBS in PD. The results from this study will significantly advance the development of CR-DBS for the treatment of PD. Findings in this study will also provide the rationale for further development of this novel DBS approach for other neurological and psychiatric disorders.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-01-05; most recent amendment 2026-07-08.
Trial Details
NCT Number NCT07340073
Lead Sponsor University of Minnesota
Conditions Parkinson's Disease (PD), Deep Brain Stimulation
Enrollment 24 participants
Start Date 2026-09-01
Primary Completion 2031-01-01 (estimated)
Study Completion 2031-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-10